Zacks.com on MSN8h
4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow
The biotech sector witnessed a see-saw performance in 2024. While the year started on a positive note, much of the gains ...
Nature1d
Transporters in drug development: advancing on the Critical Path
Recognizing that regulators have a key role to play in addressing this problem, the FDA launched the Critical Path Initiative to identify and prioritize the most pressing drug development issues ...